Billy Wynne
Agency Seeks Public Input on National AI Strategy to Tackle Chronic Disease and Advance Biomedical Innovation; Comments Due July 15 The National Institutes of Health (NIH) issued a Request for Information (RFI) to gather public input on the development of a comprehensive NIH Artificial Intelligence (AI) Strategy. The strategy will guide NIH efforts to harness…
Read MoreAgency Roundtable Highlights Urgency, Barriers, and Opportunities in Advancing Cell and Gene Therapies The Food and Drug Administration (FDA), through its Center for Biologics Evaluation and Research (CBER) convened a high-level roundtable on cell and gene therapy (CGT), bringing together leading scientists, clinicians, federal officials, and patient advocates. Moderated by CBER Director Dr. Vinay Prasad,…
Read MoreGAO Report Finds HHS Lacks Coordinated National Strategy for Pandemic Diagnostic Testing The Government Accountability Office (GAO) released a report demonstrating findings that the Department of Health and Human Services (HHS) lacks a coordinated, national approach for diagnostic testing related to infectious diseases with pandemic potential. HHS leads federal efforts through agencies such as the…
Read MoreOIG Identifies $50 Billion in Potential Cost Savings Through Payment Recovery and Program Improvements The Department of Health and Human Services Office of Inspector General (HHS OIG) released a report identifying $50 billion in potential cost savings through payment recovery and program improvements based on HHS-OIG work. There are 35 OIG reports identified for potential cost…
Read MoreHouse Votes to Approve Budget Reconciliation Bill, 215-214 The House of Representatives approved their budget reconciliation bill by a vote of 215-214, with Reps. Thomas Massie (R-KY) and Warren Davidson (R-OH) as the only Republicans to vote against the bill. Earlier in the day, the bill cleared the last hurdle to advancing to the House…
Read MoreSubcommittee on Commerce, Manufacturing, and Trade Weighs 10-Year Ban on State AI Laws Amid Debate Over Innovation and Consumer Protection The House Energy and Commerce Subcommittee on Commerce, Manufacturing, and Trade held a hearing on AI regulation and U.S. competitiveness. The hearing focused heavily on a contentious proposal for a 10-year federal moratorium on state-level…
Read MoreDr. Makary Reveals 5.5% FDA Budget Cut at Hearing; Senators Raise Alarms on Recent RIFs and Reported Delays at the Agency The Senate Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies held a hearing with Commissioner of the Food and Drug Administration (FDA), Dr. Martin Makary, to review the Fiscal…
Read MoreFTC Finalizes Order Against Welsh Carson for Antitrust Violations in Texas Anesthesiology Market On May 20, 2025, the Federal Trade Commission (FTC) finalized a consent order with private equity firm Welsh, Carson, Anderson & Stowe (Welsh Carson) and its affiliates, resolving allegations that the firm orchestrated a years-long consolidation strategy in Texas’s anesthesiology market through…
Read MoreRFK Jr. Faces Continued Bipartisan Pushback on HHS Budget; Alarms Raised Over Cuts and Program Eliminations The Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies held a hearing to review the Fiscal Year (FY) 2026 budget for the Department of Health and Human Services (HHS) with Secretary Robert F. Kennedy…
Read MoreNew Framework for COVID-19 Vaccination Released; Vaccination Recommended for Individuals with Risk Factors and Adults Over the Age of 64 Food and Drug Administration (FDA) Commissioner Marty Makary and Director of the Center for Biologics Evaluation and Research (CBER) released a new framework for COVID-19 vaccination, in which the agency will recommend vaccination for adults…
Read More